Mathematics
Competing Risks
100%
Transformation Model
51%
Semiparametric Model
51%
Survival Data
45%
Accelerated Failure Time Model
44%
Recurrent Events
40%
Cancer
32%
Simulation Study
32%
Proportion
28%
Failure Time
28%
Mixture Model
24%
Quantile Regression
23%
Covariates
23%
Demonstrate
22%
Soft Tissue
22%
Blood
22%
Model
22%
Censored Regression
22%
Estimating Function
21%
Non-proportional Hazards
21%
Red Blood Cells
19%
Regression
19%
Observed Information
19%
Cure Rate Model
19%
Estimator
17%
First Hitting Time
17%
Information Matrix
17%
Statistical Inference
16%
Risk Analysis
16%
Linear Transformation Model
16%
Latent Class Analysis
15%
Doubly Censored Data
15%
Cumulative Incidence Function
15%
Frailty
15%
Nonparametric Maximum Likelihood Estimation
15%
Frailty Model
15%
Prediction
14%
Inverse Model
14%
Biomarkers
13%
Component Model
13%
Estimate
12%
Model-based
12%
Nonparametric Likelihood
12%
Public Health
12%
Inverse Gaussian
12%
Degradation
12%
Least Squares Regression
12%
Statistical Analysis
12%
Proportional Odds Model
12%
Medicine & Life Sciences
Survival
34%
Frailty
25%
Erythrocytes
23%
Wounds and Injuries
23%
Latent Class Analysis
22%
Cohort Studies
21%
Joints
21%
retapamulin
19%
Clofarabine
17%
Proportional Hazards Models
16%
Blood Platelets
16%
Impetigo
15%
Idarubicin
14%
GATA2 Deficiency
14%
Hemorrhage
14%
Cytarabine
14%
Paintings
13%
Acute Myeloid Leukemia
13%
Population
13%
Mantle-Cell Lymphoma
13%
Gestational Weight Gain
13%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12%
Induction Chemotherapy
12%
Republic of Korea
12%
Blood Transfusion
12%
Emergency Medicine
11%
Hypertrophic Cardiomyopathy
11%
Therapeutics
11%
Induced Pluripotent Stem Cells
11%
Least-Squares Analysis
11%
Fibrinolysis
11%
Protein-Tyrosine Kinases
11%
Ointments
11%
Rituximab
11%
Acute Coronary Syndrome
10%
Traumatic Brain Injury
10%
Multicenter Studies
10%
Cystic Fibrosis
9%
Linear Models
9%
Multiple Sclerosis
9%
Longitudinal Studies
8%
Skin
8%
Pneumonia
8%
Sleep
7%
Zinc Finger Nucleases
7%
Likelihood Functions
7%
Hospitalization
7%
Surgical Blood Loss
7%
Mortality
7%
Biomarkers
7%